Clinical Research Directory
Browse clinical research sites, groups, and studies.
LLLT for BCRL: a Randomized, Placebo-controlled Study
Sponsor: National Taiwan University Hospital
Summary
This study is conducted to compare between efficacy of large and small area of low-level laser therapy (LLLT) in treatment of post mastectomy lymphedema. The change of severity of BCRL will be measured by the difference of circumference and skin thickness, detected by ultrasound. The influence on clinical symptoms, such as pain, shoulder mobility and hand function, are also investigated in the study.
Official title: Large-area Low-level Laser Therapy for Breast Cancer-related Lymphedema: a Randomized, Placebo-controlled Study
Key Details
Gender
FEMALE
Age Range
20 Years - Any
Study Type
INTERVENTIONAL
Enrollment
54
Start Date
2023-10-24
Completion Date
2025-10-31
Last Updated
2024-10-18
Healthy Volunteers
No
Conditions
Interventions
Large-area low-level laser therapy(Venusure)
The wavelength was 980±15nm, average dose was 10-40nm/cm2 and maximal output was 1000mW. Total treatment duration was 30 min and frequency was 3 sessions/week for 4 weeks; for a total of 12 sessions
Conventional low-level laser therapy
The wavelength was 808 nm and maximal output was 60 mW. Total treatment duration was 30 min and frequency was 3 sessions/week for 4 weeks; for a total of 12 sessions.
Locations (1)
National Taiwan University Hospital
Taipei, Taiwan